Sr One Capital Management, LP Design Therapeutics, Inc. Transaction History
Sr One Capital Management, LP
- $269 Million
- Q4 2024
A detailed history of Sr One Capital Management, LP transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Sr One Capital Management, LP holds 6,526,476 shares of DSGN stock, worth $31.7 Million. This represents 14.99% of its overall portfolio holdings.
Number of Shares
6,526,476
Previous 6,526,476
-0.0%
Holding current value
$31.7 Million
Previous $35.1 Million
14.68%
% of portfolio
14.99%
Previous 11.88%
Shares
2 transactions
Others Institutions Holding DSGN
# of Institutions
97Shares Held
32.1MCall Options Held
4.6KPut Options Held
2.6K-
Logos Global Management LP San Francisco, CA4.22MShares$20.5 Million3.42% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$11.2 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.95MShares$9.49 Million0.72% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.86MShares$9.02 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.74MShares$8.47 Million0.12% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $271M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...